Schedule 13G ownership disclosure
BioMarin Pharmaceutical Inc
Security class unavailable · CUSIP: 09061G101
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 16,369,689
- Percent of class
- 9.0200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-017581
- Form type
- SC 13G
- Filer
- BIOMARIN PHARMACEUTICAL INC
- CIK
- CIK 1048477
- Filed
- Feb 10, 2021
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership